Afatinib/erlotinib/gefitinibAcquired resistance in non-small cell lung cancer: case report

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2018年 / 1705卷 / 1期
关键词：
D O I：
10.1007/s40278-018-47032-5
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：15 / 15
相关论文
共 50 条
  • [41] OsimertinibAcquired drug resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2018, 1721 (1) : 226 - 226
  • [42] Alectinib/crizotinibDevelopment of resistance in non-small cell lung cancer: case report
    Reactions Weekly, 2016, 1616 (1) : 15 - 15
  • [43] Clinical perspective of afatinib in non-small cell lung cancer
    Chen, Xiaofeng
    Zhu, Quan
    Zhu, Lingjun
    Pei, Dong
    Liu, Yiqian
    Yin, Yongmei
    Schuler, Martin
    Shu, Yongqian
    LUNG CANCER, 2013, 81 (02) : 155 - 161
  • [44] Afatinib: A Review in Advanced Non-Small Cell Lung Cancer
    Keating, Gillian M.
    TARGETED ONCOLOGY, 2016, 11 (06) : 825 - 835
  • [45] Afatinib: A Review in Advanced Non-Small Cell Lung Cancer
    Gillian M. Keating
    Targeted Oncology, 2016, 11 : 825 - 835
  • [46] Afatinib treatment in advanced non-small cell lung cancer
    Hurwitz, Jane L.
    Scullin, Paula
    Campbell, Lynn
    LUNG CANCER-TARGETS AND THERAPY, 2011, 2 : 47 - 57
  • [47] Afatinib for the treatment of metastatic non-small cell lung cancer
    Joshi, Monika
    Rizvi, Syed M.
    Belani, Chandra P.
    CANCER MANAGEMENT AND RESEARCH, 2015, 7 : 75 - 82
  • [48] The safety of afatinib for the treatment of non-small cell lung cancer
    Barron, Feliciano
    de la Torre-Vallejo, Martha
    Luz Luna-Palencia, Rosa
    Cardona, Andres F.
    Arrieta, Oscar
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (11) : 1563 - 1572
  • [49] A Phase Ib/II Study of Afatinib in Combination with Nimotuzumab in Non-Small Cell Lung Cancer Patients with Acquired Resistance to Gefitinib or Erlotinib
    Lee, Ji Yun
    Sun, Jong-Mu
    Lim, Sung Hee
    Kim, Hae Su
    Yoo, Kwai Han
    Jung, Ki Sun
    Song, Haa-Na
    Ku, Bo Mi
    Koh, Jiae
    Bae, Yeon-Hee
    Lee, Se-Hoon
    Ahn, Jin Seok
    Park, Keunchil
    Ahn, Myung-Ju
    CLINICAL CANCER RESEARCH, 2016, 22 (09) : 2139 - 2145
  • [50] Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
    Kim, Youjin
    Lee, Se-Hoon
    Ahn, Jin Seok
    Ahn, Myung-Ju
    Park, Keunchil
    Sun, Jong-Mu
    CANCER RESEARCH AND TREATMENT, 2019, 51 (02): : 502 - 509
12345